Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Glaxosmithkline Plc
Relationship:   10% Owner
City:   Brentford Middlesex
State:   X0
   
Insider Summary:
  
   
Companies Owned :   30    
Direct Shares   0    

Indirect Shares

   354,639,946      
Direct Value   $0    

Indirect Value

   $1,071,050,381      
Total Shares   354,639,946      
Total Value   $1,071,050,381      


                                          Charting Not Avaliable
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    3   
    1    

     Stock price went up :
    2   
    1    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   2.0   
   1.0   
     Percentage Gain/Loss :
   23.5%
 18.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Quest Diagnostics Inc DGX Director, 10% Owner 2004-06-25 0 2011-01-31 0    Premium*  
            Redpoint Bio Corp RPBC 10% Owner 0 2007-03-12 7,456,899    Premium*  
            Maxygen Inc MAXY 10% Owner 2003-08-05 0 2009-12-30 1,433,361    Premium*  
            Amicus Therapeutics Inc FOLD Former 10% Owner (1) 0 2014-10-27 0    Premium*  
            Innoviva Inc INVA 10% Owner 2010-11-29 0 2021-05-20 0    Premium*  
            Chemocentryx, Inc. CCXI Former 10% holder 0 2018-10-16 0    Premium*  
            Human Genome Sciences Inc HGSI Director, 10% Owner 2012-07-30 0 2012-08-02 233,716,708    Premium*  
            Response Genetics Inc RGDX 10% Owner 0 2012-09-13 5,000,000    Premium*  
            Genocea Biosciences, Inc. GNCA 10% Owner 2014-02-10 0 2020-07-24 4,626,389    Premium*  
            Concert Pharmaceuticals, Inc. CNCE Former 10% Owner 2014-02-19 0 2014-02-19 1,356,533    Premium*  
            Applied Genetic Technologies Corp AGTC Former 10% Owner 2014-04-01 0 2015-02-23 1,436,448    Premium*  
            Theravance Biopharma, Inc. TBPH Former 10% Owner 0 2022-09-16 0    Premium*  
            Htg Molecular Diagnostics, Inc HTGM Former 10% Owner 2015-05-11 0 2017-03-27 792,781    Premium*  
            Crispr Therapeutics Ag CRSP 10% Owner 2016-10-24 0 2016-10-24 3,220,627    Premium*  
            Spero Therapeutics Inc SPRO 10% Owner 2017-11-06 0 2022-11-07 9,190,606    Premium*  
            Translate Bio, Inc. TBIO 10% Owner 2018-07-02 0 2018-07-02 3,697,912    Premium*  
            Liquidia Technologies Inc LQDA Former 10% holder 2018-07-30 0 2018-07-30 624,422    Premium*  
            Principia Biopharma Inc PRNB Former 10% Owner 2018-09-18 0 2019-10-18 2,982,855    Premium*  
            Turning Point Therapeutics, Inc. TPTX Director 2019-04-22 0 2020-05-21 2,253,660    Premium*  
            Bicycle Therapeutics Ltd BCYC 10% Owner 2019-05-28 0 2020-07-15 1,910,531    Premium*  
            Morphic Holding, Inc. MORF Director 2019-07-01 0 2019-07-01 2,633,772    Premium*  
            Fulcrum Therapeutics, Inc. FULC 2019-07-22 0 2019-07-22 1,785,714    Premium*  
            Progyny, Inc. PGNY 10% Owner 0 2020-05-20 6,238,244    Premium*  
            Orchard Therapeutics Plc ORTX Director, 10% Owner 0 2020-01-01 12,455,252    Premium*  
            Nkarta, Inc. NKTX Director, 10% Owner 2020-07-14 0 2020-07-14 3,150,732    Premium*  
            Pandion Therapeutics, Inc. PAND Director, 10% Owner 2020-07-21 0 2020-07-21 2,248,304    Premium*  
            Decibel Therapeutics, Inc. DBTX Director 2021-02-17 0 2021-02-17 1,183,663    Premium*  
            Lyell Immunopharma, Inc. LYEL 10% Owner 2021-06-21 0 2021-06-21 30,253,189    Premium*  
            Cvrx, Inc. CVRX 10% Owner 2021-07-02 0 2021-07-02 1,007,583    Premium*  
            Wave Life Sciences Ltd. WVE 10% Owner 0 2023-12-07 13,983,761    Premium*  
* Premium Members only  

Records found :    107         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AGTC Applied Genetic Technolog... 10% Owner   –       –       •   2014-04-01 4 B $12.00 $1,245,144 I/I 103,762 1,989,598 1.5 -
AGTC Applied Genetic Technolog... 10% Owner   –       –       •   2014-04-01 4 A $0.00 $0 I/I 1,885,836 1,885,836 0 -
AGTC Applied Genetic Technolog... 10% Owner   –       –       •   2014-12-10 4 S $21.18 $211,760 I/I (10,000) 1,979,598 0 -
AGTC Applied Genetic Technolog... 10% Owner   –       –       •   2014-12-11 4 S $21.28 $266,035 I/I (12,500) 1,967,098 0 -
AGTC Applied Genetic Technolog... 10% Owner   –       –       •   2014-12-12 4 S $21.24 $159,294 I/I (7,500) 1,959,598 0 -
AGTC Applied Genetic Technolog... 10% Owner   –       –       •   2014-12-17 4 S $21.00 $168,000 I/I (8,000) 1,951,598 0 -
AGTC Applied Genetic Technolog... 10% Owner   –       –       •   2014-12-18 4 S $21.01 $252,136 I/I (12,000) 1,939,598 0 -
AGTC Applied Genetic Technolog... Former 10% Owner   –       –      –    2015-02-23 4 S $22.00 $11,069,602 I/I (503,150) 1,436,448 0 -
BCYC Bicycle Therapeutics Ltd Director   –       •       •   2019-05-28 4 B $14.00 $5,399,996 I/I 385,714 1,915,275 2.25 -
BCYC Bicycle Therapeutics Ltd Director   –       •       •   2019-05-28 4 A $0.00 $0 I/I 1,529,561 1,529,561 0 -
BCYC Bicycle Therapeutics Ltd 10% Owner   –       –       •   2020-07-14 4 S $19.27 $30,781 I/I (1,597) 1,913,678 0 -
BCYC Bicycle Therapeutics Ltd 10% Owner   –       –       •   2020-07-15 4 S $19.25 $61,045 I/I (3,147) 1,910,531 0 -
CCXI Chemocentryx, Inc. 10% Owner   –       –       •   2012-02-08 3 IO $0.00 $0 I/I 0 700,000 -
CCXI Chemocentryx, Inc. 10% Owner   –       –       •   2012-02-13 4 A $0.00 $0 I/I 6,643,492 7,343,492 0 -
CCXI Chemocentryx, Inc. Former 10% holder   –       –      –    2018-10-16 4 S $11.69 $85,845,421 I/I (7,343,492) 0 0 -
CNCE Concert Pharmaceuticals, ... Former 10% Owner   –       –      –    2014-02-19 4 B $14.00 $490,000 I/I 35,000 1,356,533 0.01 -
CNCE Concert Pharmaceuticals, ... Former 10% Owner   –       –      –    2014-02-19 4 A $0.00 $0 I/I 1,321,533 1,321,533 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2016-10-24 4 B $14.00 $931,000 I/I 66,500 3,220,627 1.5 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2016-10-24 4 A $0.00 $0 I/I 3,154,127 3,154,127 0 -
CVRX Cvrx, Inc. 10% Owner   –       –       •   2021-07-02 4 B $18.00 $4,950,000 I/I 275,000 1,007,583 1.5 %
CVRX Cvrx, Inc. 10% Owner   –       –       •   2021-07-02 4 A $0.00 $0 I/I 700,772 732,583 0 -
DBTX Decibel Therapeutics, Inc... Director   –       •      –    2021-02-17 4 B $18.00 $2,700,000 I/I 150,000 1,183,663 2.1 -
DBTX Decibel Therapeutics, Inc... Director   –       •      –    2021-02-17 4 A $0.00 $0 I/I 1,033,663 1,033,663 0 -
DGX Quest Diagnostics Inc 10% Owner   –       –       •   2004-06-25 4 S $86.13 $101,333,495 I/I (1,176,518) 20,952,154 -
DGX Quest Diagnostics Inc 10% Owner   –       –       •   2004-12-14 4 S $94.19 $254,313,000 I/I (2,700,000) 18,252,154 -
  107  Records found
  1  2   3   4   5      
  Page 1 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us